$1.41
-0.16-9.94%
At close: -
$1.44
0.032.49%
After Hours: 7:51 PM EDT
Comments
Loading...
Neumora Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:NMRA | Benzinga
Neumora Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.380
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Neumora Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Neumora Therapeutics (NMRA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $-0.37 | $-0.37 | 0.00 % |
| Q3 | 2024-11-12 | $-0.45 | $-0.39 | -15.4 % |
| Q2 | 2024-08-06 | $-0.37 | $-0.37 | 0.00 % |
| Q1 | 2024-05-07 | $-0.34 | $-0.34 | 0.00 % |
Neumora Therapeutics (NMRA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Neumora Therapeutics (NASDAQ:NMRA) reporting earnings?
Neumora Therapeutics (NMRA) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for Neumora Therapeutics (NASDAQ:NMRA)?
The Actual EPS was $-0.37, which hit the estimate of $-0.37.
What were Neumora Therapeutics’s (NASDAQ:NMRA) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.